Effects of glucocorticoids on STAT4 activation in human T cells are stimulus-dependent

被引:21
作者
Fahey, Angela J.
Robins, R. Adrian
Kindle, Karin B.
Heery, David M.
Constantinescu, Cris S. [1 ]
机构
[1] Univ Nottingham, Sch Med, Queens Med Ctr, Div Clin Neurol, Nottingham NG7 2UH, England
[2] Univ Nottingham, Div Mol & Clin Immunol, Nottingham NG7 2UH, England
[3] Univ Nottingham, Sch Pharm, Nottingham NG7 2UH, England
关键词
modulation; signal transduction;
D O I
10.1189/jlb.0605296
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Glucocorticoids affect the immune system by a number of mechanisms, including modulation of cytokine production in lymphocytes. Glucocorticoids suppress T helper cell type I immune responses by decreasing the ability of T cells to respond to interleukin (IL)-12, a major inducer of interferon (IFN)-gamma. IFN-beta increases the expression of the anti-inflammatory cytokine IL-10 and suppresses IL-12. Signaling pathways through IFN-beta and the IL-12 receptor (IL-12R) involve activation by phosphorylation of signal transducer and activator of transcription 4 (STAT4). Our aim was to investigate the effects of dexamethasone on STAT4 activation by IFN-P and IL-12 in human T cell blasts. We report that dexamethasone decreases IL-12-induced STAT4 phosphorylation and IFN-gamma production and enhances IFN-beta-induced STAT4 activation and IL-10 production. These effects are associated with a down-regulation of IL-12R beta 1 expression but an up-regulation of IFN-beta R. These results indicate that the effect of glucocorticoids on the STAT4 signaling pathway depends on the stimulus activating that pathway.
引用
收藏
页码:133 / 144
页数:12
相关论文
共 49 条
[1]   Cytokine-based immunointervention in the treatment of autoimmune diseases [J].
Adorini, L .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 132 (02) :185-192
[2]   Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines [J].
Agarwal, SK ;
Marshall, GD .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2001, 21 (03) :147-155
[3]  
*APPL BIOS, 2002, US B APPL BIOS
[4]   Glucocorticoids in T cell development and function [J].
Ashwell, JD ;
Lu, FWM ;
Vacchio, MS .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :309-345
[5]   Sustained IL-12 signaling is required for Th1 development [J].
Athie-Morales, V ;
Smits, HH ;
Cantrell, DA ;
Hilkens, CMU .
JOURNAL OF IMMUNOLOGY, 2004, 172 (01) :61-69
[6]   INTERLEUKIN-12 INDUCES TYROSINE PHOSPHORYLATION AND ACTIVATION OF STAT4 IN HUMAN-LYMPHOCYTES [J].
BACON, CM ;
PETRICOIN, EF ;
ORTALDO, JR ;
REES, RC ;
LARNER, AC ;
JOHNSTON, JA ;
O'SHEA, JJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7307-7311
[7]   Regulation of protein-DNA interactions at the interferon-γ gene promoter by corticosteroids -: Implications for inflammatory bowel diseases [J].
Barbulescu, K ;
Becker, C ;
ZumBüschenfelde, KHM ;
Neurath, MF .
INTESTINAL PLASTICITY IN HEALTH AND DISEASE, 1998, 859 :194-197
[8]   Interferons α and β as immune regulators -: A new look [J].
Biron, CA .
IMMUNITY, 2001, 14 (06) :661-664
[9]   Expression of IL-12 in CNS and lymphoid organs of mice with experimental allergic encephalitis [J].
Bright, JJ ;
Musuro, BF ;
Du, C ;
Sriram, S .
JOURNAL OF NEUROIMMUNOLOGY, 1998, 82 (01) :22-30
[10]   INTERFERON-ALPHA INCREASES THE FREQUENCY OF INTERFERON-GAMMA-PRODUCING HUMAN CD4+ T-CELLS [J].
BRINKMANN, V ;
GEIGER, T ;
ALKAN, S ;
HEUSSER, CH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) :1655-1663